Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CCR2 | P41597 | 7/20 | 0.51 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | USP5 | P45974 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3049934 | 0.95 | L3MBTL3 (0.49) | L3MBTL3L3MBTL1CCR2BDKRB1KCNH2 | |
| SCHEMBL3144249 | 0.94 | CCR2 (0.50) | L3MBTL3L3MBTL1CCR2BDKRB1KCNH2 | |
| SCHEMBL3147720 | 0.92 | CCR2 (0.52) | L3MBTL3L3MBTL1CCR2KCNH2CHRM4 | |
| SCHEMBL3153072 | 0.92 | CCR2 (0.50) | L3MBTL3L3MBTL1CCR2BDKRB1KCNH2 | |
| SCHEMBL3149074 | 0.90 | CCR2 (0.59) | L3MBTL3L3MBTL1CCR2KCNH2SMN1; SMN2 | |
| SCHEMBL3149383 | 0.89 | L3MBTL3 (0.44) | L3MBTL3L3MBTL1CCR2BDKRB1KCNH2 | |
| SCHEMBL3139721 | 0.87 | CCR2 (0.55) | L3MBTL3L3MBTL1CCR2KCNH2 | |
| SCHEMBL3050672 | 0.87 | CCR2 (0.53) | CCR2BDKRB1KCNH2MEN1KMT2A | |
| SCHEMBL3139183 | 0.86 | CCR2 (0.49) | L3MBTL3L3MBTL1CCR2KCNH2ALDH1A1 | |
| SCHEMBL3149352 | 0.86 | CCR2 (0.65) | CCR2KCNH2MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074083-B1 | NEW SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | RICHTER GEDEON NYRT (HU) | 2013-06-19 | — | — | EP | claimed |
| US-20100075978-A1 | SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | RICHTER GEDEON NYRT. (HU) | 2010-03-25 | — | — | US | claimed |
| EP-2074083-B1 | NEW SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | RICHTER GEDEON NYRT (HU) | 2013-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100075978-A1 | SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | BDKRB1, BDKRB2, TRPV1 | L3MBTL3 3807/4885L3MBTL1 3132/4885CCR2 417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.